Literature DB >> 15930073

Informed consent in medication-free schizophrenia research.

David J Moser1, Rebecca L Reese, Susan K Schultz, Michelle L Benjamin, Stephan Arndt, Frank W Fleming, Nancy C Andreasen.   

Abstract

OBJECTIVE: The authors' goal was to determine whether people with schizophrenia experience changes in decisional capacity when their antipsychotic regimens are discontinued for research purposes.
METHOD: Capacity for informed consent for research, neuropsychological performance, and psychiatric symptoms were assessed before and after discontinuation of antipsychotic medication in 10 individuals with schizophrenia.
RESULTS: Overall, participants showed minimal change on most measures during the medication-free interval, although their reasoning ability declined significantly. All participants who demonstrated adequate understanding of study procedures at enrollment retained this capacity throughout the study.
CONCLUSIONS: Participants in medication-free schizophrenia research do not show a major decline in decisional capacity. However, the apparent decline in reasoning ability found in this study is of concern and underscores the need for both additional research on this topic and the development of remediational interventions aimed at enhancing this aspect of decisional capacity.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Substances:

Year:  2005        PMID: 15930073     DOI: 10.1176/appi.ajp.162.6.1209

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  13 in total

1.  Ethical concerns in schizophrenia research: looking back and moving forward.

Authors:  Scott T Wilson; Barbara Stanley
Journal:  Schizophr Bull       Date:  2005-11-10       Impact factor: 9.306

2.  A summary of important documents in the field of research ethics.

Authors:  Bernard A Fischer
Journal:  Schizophr Bull       Date:  2005-09-28       Impact factor: 9.306

Review 3.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

4.  Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.

Authors:  T Scott Stroup; Paul S Appelbaum; Hongbin Gu; Spencer Hays; Marvin S Swartz; Richard S E Keefe; Scott Y Kim; Theo C Manschreck; Roger A Boshes; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  Schizophr Res       Date:  2011-05-10       Impact factor: 4.939

5.  Meta-consent in research on decisional capacity: a "Catch-22"?

Authors:  Elyn R Saks; Laura B Dunn; Barton W Palmer
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

6.  Decisional capacity of patients with schizophrenia to consent to research: taking stock.

Authors:  Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

7.  Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study.

Authors:  T Scott Stroup; Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-11-10       Impact factor: 9.306

Review 8.  A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia.

Authors:  Tim Calton; Michael Ferriter; Nick Huband; Helen Spandler
Journal:  Schizophr Bull       Date:  2007-06-14       Impact factor: 9.306

9.  Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects.

Authors:  James Dubois; Holly Bante; Whitney B Hadley
Journal:  AJOB Prim Res       Date:  2011-12-06

10.  Hidden Empirical Research Ethics: A Review of Three Health Journals from 2005 through 2006.

Authors:  James M Dubois; Rebecca L Volpe; Erica K Rangel
Journal:  J Empir Res Hum Res Ethics       Date:  2008-09       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.